Presentation TCT 2025 Commentary Presenter: Fernando Alfonso October 26, 2025 REGISTER for free or LOG IN to view this content TCT 2025 Up Next Presentation TCT 2025 Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis Presenter: Donald Cutlip October 26, 2025 More slides + Presentation TCT 2025 Commentary Presenter: Robert A. Byrne October 26, 2025 Presentation TCT 2025 Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions Presenter: Sahil A. Parikh October 26, 2025 We Recommend Disclosures <p>Nothing to disclose</p>
Presentation TCT 2025 Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis Presenter: Donald Cutlip October 26, 2025
Presentation TCT 2025 Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions Presenter: Sahil A. Parikh October 26, 2025